Eastgate Biotech Statistics
Total Valuation
ETBI has a market cap or net worth of 4.23 million.
| Market Cap | 4.23M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
ETBI has 1.06 billion shares outstanding.
| Current Share Class | 1.06B |
| Shares Outstanding | 1.06B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +93.61% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.74 |
| PB Ratio | -0.80 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.70 |
| Interest Coverage | -15.17 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 68.70% |
| Revenue Per Employee | 45,879 |
| Profits Per Employee | -1.27M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.89% in the last 52 weeks. The beta is -3,790.01, so ETBI's price volatility has been lower than the market average.
| Beta (5Y) | -3,790.01 |
| 52-Week Price Change | -98.89% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 52.93 |
| Average Volume (20 Days) | 179,960 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.45 |
Income Statement
In the last 12 months, ETBI had revenue of 137,638 and -3.82 million in losses. Loss per share was -0.01.
| Revenue | 137,638 |
| Gross Profit | -11,637 |
| Operating Income | -3.63M |
| Pretax Income | -3.82M |
| Net Income | -3.82M |
| EBITDA | -3.55M |
| EBIT | -3.63M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 4,911 in cash and 3.08 million in debt, giving a net cash position of -3.07 million or -0.00 per share.
| Cash & Cash Equivalents | 4,911 |
| Total Debt | 3.08M |
| Net Cash | -3.07M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -5.29M |
| Book Value Per Share | -0.00 |
| Working Capital | -6.79M |
Cash Flow
In the last 12 months, operating cash flow was -1.76 million and capital expenditures -51,684, giving a free cash flow of -1.81 million.
| Operating Cash Flow | -1.76M |
| Capital Expenditures | -51,684 |
| Free Cash Flow | -1.81M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | -8.45% |
| Operating Margin | -2,640.79% |
| Pretax Margin | -2,774.35% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ETBI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -87.04% |
| Shareholder Yield | n/a |
| Earnings Yield | -90.24% |
| FCF Yield | -42.74% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ETBI has an Altman Z-Score of -26.94. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.94 |
| Piotroski F-Score | n/a |